(Q38492082)

3 September 2017

Peptide-hormone- and serotonin-immunoreactive tumour cells in carcinoma of the prostate (English)

1 reference

3 September 2017

Abrahamsson PA

1

1 reference

3 September 2017

Wadström LB

2

1 reference

3 September 2017

Alumets J

3

1 reference

3 September 2017

Falkmer S

4

1 reference

3 September 2017

Grimelius L

5

1 reference

3 September 2017

language of work or name

1 reference

1 June 1987

1 reference

Pathology, Research and Practice

3 September 2017

1 reference

3 September 2017

182

1 reference

3 September 2017

298-307

1 reference

3 September 2017

3

1 reference

Peptide-hormone- and serotonin-immunoreactive cells in normal and hyperplastic prostate glands

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2887%2980065-1

7 January 2021

Primary prostatic carcinoid tumor with intracytoplasmic prostatic acid phosphatase and prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2887%2980065-1

7 January 2021

Argentaffin cells in prostatic carcinoma: differentiation from lipofuscin and melanin in prostatic epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2887%2980065-1

7 January 2021

Amphicrine cells, dysplasias, and neoplasias

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2887%2980065-1

7 January 2021

Multidirectional differentiation in neuroendocrine neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2887%2980065-1

7 January 2021

Endocrine cells in the prostate gland, urothelium and Brenner tumors. Immunohistological and ultrastructural studies

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2887%2980065-1

7 January 2021

Symptomatic hypokalemic alkalosis in hyperadrenocorticism secondary to carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2887%2980065-1

7 January 2021

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2887%2980065-1

7 January 2021

Argentaffin and argyrophil cells in the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2887%2980065-1

7 January 2021

Motilin cells investigated by the use of region-specific antisera

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2887%2980065-1

7 January 2021

Carcinoid tumor of the prostate associated with adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2887%2980065-1

7 January 2021

Identification and characterization of enterochromaffin cells with different staining techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2887%2980065-1

7 January 2021

Inappropriate secretion of antidiuretic hormone by carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2887%2980065-1

7 January 2021

Neurohormonal peptide immunoreactive cells in mucinous cystadenomas and cystadenocarcinomas of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2887%2980065-1

7 January 2021

Mammary carcinoma with argyrophil cells

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2887%2980065-1

7 January 2021

Relationship of ectopic ACTH production to tumor differentiation: A morphologic and immunohistochemical study of prostatic carcinoma with cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2887%2980065-1

7 January 2021

Primary carcinoid of prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2887%2980065-1

7 January 2021

Diffuse carcinoid of prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2887%2980065-1

7 January 2021

Ectopic ACTH, prostatic oat cell carcinoma, and marked hypernatremia

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2887%2980065-1

7 January 2021

10.1016/S0344-0338(87)80065-1

Identifiers

DOI

0 references

1 reference